89bio Inc. (ETNB) NASDAQ
$9.18 0.02 (0.22%)
Market Cap: $856.47M
As of 04/18/24 12:27 PM EDT. Market open.
89bio Inc. (ETNB)
NASDAQ
$9.18
0.02 (0.22%)
Market Cap: $856.47M
As of 04/18/24 12:27 PM EDT. Market open.
Add to Portfolio
89bio, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. its lead product candidate is bio89-100, a glycopegylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. the company also intends to develop bio89-100 for the treatment of severe ... read more
89bio, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. its lead product candidate is bio89-100, a glycopegylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. the company also intends to develop bio89-100 for the treatment of severe hypertriglyceridemia. 89bio, inc. was founded in 2018 and is based in san francisco, california. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
45
URL
Address
.
PRICE CHART FOR 89BIO INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.21
Previous Close
$9.16
Days Range
$9.12 - $9.57
52 week range
$6.58 - $22.93
Volume
138,960
Avg. Volume (30 days)
823,484
Market Cap
$856.47M
Dividend Yield
-
P/E
-
Shares Outstanding
93,501,210
Open
$9.21
Previous Close
$9.16
Days Range
$9.12 - $9.57
52 week range
$6.58 - $22.93
Volume
138,960
Avg. Volume (30 days)
823,484
Market Cap
$856.47M
Dividend Yield
-
P/E
-
Shares Outstanding
93,501,210
FINANCIAL STATEMENTS FOR 89BIO INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR 89BIO INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | Director | Apr 11, 2024 | Option Exercise | $5.32 | 1,408,450 | 7,499,996 | 13,840,034 | Apr 15, 2024, 04:15 PM |
| PALEKAR ROHAN | Chief Executive Officer | Apr 01, 2024 | Option Exercise | $1.93 | 25,000 | 48,250 | 511,889 | Apr 03, 2024, 04:01 PM |
| PALEKAR ROHAN | Chief Executive Officer | Apr 01, 2024 | Sale | $10.91 | 52,718 | 575,153 | 459,171 | Apr 03, 2024, 04:01 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Mar 04, 2024 | Buy | $15.35 | 1,350,000 | 20,722,501 | 12,431,584 | Mar 06, 2024, 05:40 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 26, 2024 | Sale | $10.76 | 4,477 | 48,173 | 486,889 | Feb 28, 2024, 06:43 PM |
| Martins Ryan | Chief Financial Officer | Feb 17, 2024 | Option Exercise | $9.74 | 778 | 7,578 | 106,609 | Feb 23, 2024, 08:55 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 17, 2024 | Option Exercise | $9.74 | 4,602 | 44,823 | 491,366 | Feb 23, 2024, 08:51 PM |
| Le-Nguyen Quoc | See Remarks | Feb 17, 2024 | Option Exercise | $9.74 | 1,046 | 10,188 | 222,149 | Feb 23, 2024, 08:50 PM |
| Mansbach Harry H | Chief Medical Officer | Feb 17, 2024 | Option Exercise | $9.74 | 1,046 | 10,188 | 158,437 | Feb 23, 2024, 08:41 PM |
| Martins Ryan | Chief Financial Officer | Feb 09, 2024 | Option Exercise | $8.45 | 3,568 | 30,150 | 107,387 | Feb 13, 2024, 09:12 PM |
| Mansbach Harry H | Chief Medical Officer | Feb 09, 2024 | Option Exercise | $8.45 | 3,568 | 30,150 | 159,483 | Feb 13, 2024, 09:04 PM |
| Le-Nguyen Quoc | See Remarks | Feb 09, 2024 | Option Exercise | $8.45 | 3,568 | 30,150 | 223,195 | Feb 13, 2024, 09:02 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 09, 2024 | Option Exercise | $8.45 | 12,670 | 107,061 | 480,968 | Feb 13, 2024, 08:58 PM |
| Mansbach Harry H | Chief Medical Officer | Feb 05, 2024 | Option Exercise | $9.80 | 1,190 | 11,662 | 163,051 | Feb 05, 2024, 08:22 PM |
| Le-Nguyen Quoc | See Remarks | Feb 05, 2024 | Option Exercise | $9.80 | 1,190 | 11,662 | 226,763 | Feb 05, 2024, 08:22 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 05, 2024 | Option Exercise | $9.80 | 5,068 | 49,666 | 493,646 | Feb 05, 2024, 08:16 PM |
| Martins Ryan | Chief Financial Officer | Feb 05, 2024 | Option Exercise | $9.80 | 892 | 8,742 | 110,955 | Feb 05, 2024, 08:07 PM |
| Mansbach Harry H | Chief Medical Officer | Jan 05, 2024 | Option Exercise | $11.53 | 9,671 | 111,507 | 115,491 | Jan 08, 2024, 07:00 PM |
| Martins Ryan | Chief Financial Officer | Jan 05, 2024 | Option Exercise | $11.53 | 6,124 | 70,610 | 63,097 | Jan 08, 2024, 06:35 PM |
| Le-Nguyen Quoc | See Remarks | Jan 05, 2024 | Option Exercise | $11.53 | 9,671 | 111,507 | 179,203 | Jan 08, 2024, 06:32 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jan 05, 2024 | Option Exercise | $11.53 | 27,511 | 317,202 | 348,714 | Jan 08, 2024, 06:31 PM |
| PALEKAR ROHAN | Chief Executive Officer | Dec 29, 2023 | Option Exercise | $1.93 | 50,000 | 96,500 | 351,225 | Jan 03, 2024, 04:54 PM |
| PALEKAR ROHAN | Chief Executive Officer | Dec 29, 2023 | Sale | $11.20 | 50,000 | 560,000 | 301,225 | Jan 03, 2024, 04:54 PM |
| Mansbach Harry H | Chief Medical Officer | Sep 09, 2023 | Option Exercise | $16.61 | 3,821 | 63,467 | 100,162 | Sep 12, 2023, 04:06 PM |
| Martins Ryan | Chief Financial Officer | Sep 09, 2023 | Option Exercise | $16.61 | 2,074 | 34,449 | 54,221 | Sep 12, 2023, 04:05 PM |
| Le-Nguyen Quoc | See Remarks | Sep 09, 2023 | Option Exercise | $16.61 | 4,958 | 82,352 | 163,874 | Sep 12, 2023, 04:05 PM |
| Mansbach Harry H | Chief Medical Officer | Aug 17, 2023 | Option Exercise | $15.46 | 1,014 | 15,676 | 103,983 | Aug 21, 2023, 05:51 PM |
| Mansbach Harry H | Chief Medical Officer | Aug 01, 2023 | Option Exercise | $15.64 | 577 | 9,024 | 104,997 | Aug 21, 2023, 05:51 PM |
| PALEKAR ROHAN | Chief Executive Officer | Aug 17, 2023 | Option Exercise | $15.46 | 4,501 | 69,585 | 300,950 | Aug 21, 2023, 05:49 PM |
| Martins Ryan | Chief Financial Officer | Aug 01, 2023 | Option Exercise | $15.64 | 346 | 5,411 | 57,048 | Aug 21, 2023, 05:45 PM |
| Martins Ryan | Chief Financial Officer | Aug 17, 2023 | Option Exercise | $15.46 | 753 | 11,641 | 56,295 | Aug 21, 2023, 05:45 PM |
| Le-Nguyen Quoc | See Remarks | Aug 01, 2023 | Option Exercise | $15.53 | 1,591 | 24,701 | 169,846 | Aug 21, 2023, 05:43 PM |
| LAPORTE KATHLEEN | Director | Jul 17, 2023 | Option Exercise | $2.64 | 12,500 | 33,000 | 12,500 | Jul 18, 2023, 06:04 PM |
| LAPORTE KATHLEEN | Director | Jul 17, 2023 | Sale | $18.80 | 12,500 | 235,000 | 0 | Jul 18, 2023, 06:04 PM |
| Mansbach Harry H | Chief Medical Officer | Jun 30, 2023 | Option Exercise | $18.95 | 2,882 | 54,614 | 105,574 | Jul 05, 2023, 08:54 PM |
| Le-Nguyen Quoc | See Remarks | Jun 30, 2023 | Option Exercise | $18.95 | 2,882 | 54,614 | 170,423 | Jul 05, 2023, 08:43 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jun 30, 2023 | Option Exercise | $18.95 | 16,527 | 313,187 | 305,451 | Jul 05, 2023, 08:39 PM |
| Martins Ryan | Chief Financial Officer | Jun 30, 2023 | Option Exercise | $18.95 | 2,018 | 38,241 | 57,394 | Jul 05, 2023, 08:36 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jun 05, 2023 | Option Exercise | $1.93 | 15,000 | 28,950 | 301,978 | Jun 07, 2023, 05:04 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jun 05, 2023 | Sale | $20.00 | 15,000 | 300,000 | 286,978 | Jun 07, 2023, 05:04 PM |
| Atkinson Edward Morrow III | Director | Jun 01, 2023 | Option Exercise | $2.61 | 6,250 | 16,312 | 6,250 | Jun 05, 2023, 05:03 PM |
| Atkinson Edward Morrow III | Director | Jun 01, 2023 | Sale | $17.91 | 6,250 | 111,937 | 0 | Jun 05, 2023, 05:03 PM |
| Le-Nguyen Quoc | See Remarks | May 09, 2023 | Option Exercise | $3.11 | 79,571 | 247,466 | 178,654 | May 11, 2023, 05:01 PM |
| Le-Nguyen Quoc | See Remarks | May 09, 2023 | Sale | $18.11 | 13,683 | 247,799 | 164,971 | May 11, 2023, 05:01 PM |
| Martins Ryan | Chief Financial Officer | Apr 04, 2023 | Sale | $14.95 | 8,721 | 130,379 | 53,578 | Apr 06, 2023, 04:06 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Mar 24, 2023 | Buy | $16.25 | 2,461,538 | 39,999,993 | 11,081,584 | Mar 30, 2023, 05:00 PM |
| Hayden Michael R | Director | Mar 30, 2022 | Buy | $3.62 | 6,250 | 22,625 | 83,978 | Mar 30, 2023, 04:26 PM |
| Hayden Michael R | Director | Mar 28, 2023 | Buy | $16.15 | 61,538 | 993,839 | 61,538 | Mar 30, 2023, 04:26 PM |
| Hayden Michael R | Director | Apr 25, 2022 | Buy | $2.67 | 10,000 | 26,700 | 103,978 | Mar 30, 2023, 04:26 PM |
| Hayden Michael R | Director | Apr 07, 2022 | Buy | $3.47 | 10,000 | 34,750 | 93,978 | Mar 30, 2023, 04:26 PM |
| Martins Ryan | Chief Financial Officer | Mar 23, 2023 | Sale | $16.11 | 5,000 | 80,550 | 53,578 | Mar 27, 2023, 07:20 PM |
| PALEKAR ROHAN | Chief Executive Officer | Mar 23, 2023 | Sale | $16.00 | 15,000 | 240,000 | 269,080 | Mar 27, 2023, 07:18 PM |
| Mansbach Harry H | Chief Medical Officer | Feb 17, 2023 | Option Exercise | $13.97 | 2,127 | 29,714 | 94,671 | Feb 22, 2023, 06:41 PM |
| Martins Ryan | Chief Financial Officer | Feb 17, 2023 | Option Exercise | $13.97 | 1,750 | 24,448 | 61,118 | Feb 22, 2023, 06:39 PM |
| Martins Ryan | Chief Financial Officer | Feb 21, 2023 | Sale | $13.89 | 2,540 | 35,281 | 58,578 | Feb 22, 2023, 06:39 PM |
| Le-Nguyen Quoc | See Remarks | Feb 17, 2023 | Option Exercise | $13.97 | 2,140 | 29,896 | 91,179 | Feb 22, 2023, 06:39 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 17, 2023 | Option Exercise | $13.97 | 6,279 | 87,718 | 284,072 | Feb 22, 2023, 06:38 PM |
| Martins Ryan | Chief Financial Officer | Feb 08, 2023 | Sale | $14.41 | 1,480 | 21,327 | 32,868 | Feb 10, 2023, 05:32 PM |
| Mansbach Harry H | Chief Medical Officer | Feb 05, 2023 | Option Exercise | $13.24 | 1,360 | 18,006 | 66,798 | Feb 07, 2023, 07:38 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 05, 2023 | Option Exercise | $13.24 | 4,078 | 53,993 | 215,351 | Feb 07, 2023, 07:36 PM |
| Martins Ryan | Chief Financial Officer | Feb 05, 2023 | Option Exercise | $13.24 | 592 | 7,838 | 34,348 | Feb 07, 2023, 07:36 PM |
| Martins Ryan | Chief Financial Officer | Feb 03, 2023 | Option Exercise | $3.11 | 3,000 | 9,330 | 38,960 | Feb 07, 2023, 07:36 PM |
| Martins Ryan | Chief Financial Officer | Feb 03, 2023 | Sale | $13.04 | 3,592 | 46,848 | 38,960 | Feb 07, 2023, 07:36 PM |
| Le-Nguyen Quoc | See Remarks | Feb 05, 2023 | Option Exercise | $13.24 | 1,390 | 18,404 | 63,319 | Feb 07, 2023, 07:35 PM |
| Martins Ryan | Chief Financial Officer | Feb 01, 2023 | Option Exercise | $12.05 | 408 | 4,916 | 35,960 | Feb 03, 2023, 05:10 PM |
| Mansbach Harry H | Chief Medical Officer | Feb 01, 2023 | Option Exercise | $12.05 | 680 | 8,194 | 68,158 | Feb 03, 2023, 05:10 PM |
| Le-Nguyen Quoc | See Remarks | Feb 01, 2023 | Option Exercise | $12.05 | 695 | 8,375 | 64,709 | Feb 03, 2023, 05:08 PM |
| Martins Ryan | Chief Financial Officer | Jan 03, 2023 | Sale | $12.51 | 5,947 | 74,397 | 36,368 | Jan 05, 2023, 06:03 PM |
| Mansbach Harry H | Chief Medical Officer | Nov 15, 2022 | Option Exercise | $9.79 | 3,113 | 30,476 | 68,838 | Dec 13, 2022, 05:52 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Oct 18, 2022 | Buy | $7.65 | 1,172,741 | 8,971,469 | 8,955,410 | Oct 20, 2022, 05:28 PM |
| Le-Nguyen Quoc | See Remarks | Sep 30, 2022 | Option Exercise | $5.79 | 1,297 | 7,510 | 65,404 | Sep 30, 2022, 07:06 PM |
| Le-Nguyen Quoc | See Remarks | Sep 28, 2022 | Option Exercise | $5.76 | 2,882 | 16,600 | 62,951 | Sep 30, 2022, 07:06 PM |
| Martins Ryan | Chief Financial Officer | Sep 28, 2022 | Option Exercise | $5.76 | 2,018 | 11,624 | 42,315 | Sep 30, 2022, 07:05 PM |
| Mansbach Harry H | Chief Medical Officer | Sep 28, 2022 | Option Exercise | $5.76 | 2,882 | 16,600 | 62,951 | Sep 30, 2022, 07:04 PM |
| PALEKAR ROHAN | Chief Executive Officer | Sep 28, 2022 | Option Exercise | $5.76 | 11,527 | 66,396 | 219,429 | Sep 30, 2022, 07:02 PM |
| PALEKAR ROHAN | Chief Executive Officer | Sep 08, 2022 | Option Exercise | $1.93 | 100,000 | 193,000 | 197,623 | Sep 09, 2022, 04:39 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jul 01, 2022 | Buy | $3.55 | 2,816,900 | 9,999,995 | 7,782,669 | Jul 06, 2022, 05:27 PM |
| Mansbach Harry H | Chief Medical Officer | Feb 05, 2022 | Option Exercise | $5.23 | 1,363 | 7,128 | 31,137 | Apr 13, 2022, 04:05 PM |
| Martins Ryan | Chief Financial Officer | Feb 05, 2022 | Option Exercise | $5.23 | 1,022 | 5,345 | 22,478 | Apr 13, 2022, 04:05 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 05, 2022 | Option Exercise | $5.23 | 4,088 | 21,380 | 95,957 | Apr 13, 2022, 04:05 PM |
| Le-Nguyen Quoc | See Remarks | Feb 05, 2022 | Option Exercise | $5.23 | 1,363 | 7,128 | 31,137 | Apr 13, 2022, 04:05 PM |
| Waisbourd Ram | See Remarks | Feb 01, 2022 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Feb 03, 2022, 04:30 PM |
| Waisbourd Ram | See Remarks | Feb 01, 2022 | Sale | $5.70 | 7,000 | 39,900 | 0 | Feb 03, 2022, 04:30 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jan 28, 2022 | Buy | $6.14 | 2,500 | 15,350 | 45,845 | Jan 31, 2022, 04:30 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jan 27, 2022 | Buy | $7.50 | 5,000 | 37,500 | 43,345 | Jan 31, 2022, 04:30 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jan 26, 2022 | Sale | $8.38 | 21,482 | 180,019 | 1,829,436 | Jan 27, 2022, 05:22 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jan 25, 2022 | Sale | $8.40 | 49,091 | 412,364 | 1,840,176 | Jan 27, 2022, 05:22 PM |
| Waisbourd Ram | See Remarks | Dec 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Dec 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Dec 16, 2021 | Sale | $11.48 | 7,000 | 80,360 | 0 | Dec 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Nov 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Nov 18, 2021, 06:37 PM |
| Waisbourd Ram | See Remarks | Nov 16, 2021 | Sale | $16.49 | 7,000 | 115,430 | 0 | Nov 18, 2021, 06:37 PM |
| Waisbourd Ram | See Remarks | Oct 18, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Oct 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Oct 18, 2021 | Sale | $17.49 | 7,000 | 122,430 | 0 | Oct 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Sep 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Sep 20, 2021, 04:32 PM |
| Waisbourd Ram | See Remarks | Sep 16, 2021 | Sale | $19.46 | 7,000 | 136,220 | 0 | Sep 20, 2021, 04:32 PM |
| Waisbourd Ram | See Remarks | Aug 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Aug 18, 2021, 04:10 PM |
| Waisbourd Ram | See Remarks | Aug 16, 2021 | Sale | $18.28 | 7,000 | 127,960 | 0 | Aug 18, 2021, 04:10 PM |
| Waisbourd Ram | See Remarks | Jul 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Jul 19, 2021, 04:05 PM |
| Waisbourd Ram | See Remarks | Jul 16, 2021 | Sale | $16.80 | 7,000 | 117,600 | 0 | Jul 19, 2021, 04:05 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jul 08, 2021 | Buy | $16.25 | 2,000 | 32,500 | 37,000 | Jul 08, 2021, 04:05 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jul 07, 2021 | Buy | $17.07 | 5,000 | 85,350 | 35,000 | Jul 08, 2021, 04:05 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jun 02, 2021 | Buy | $18.77 | 22,138 | 415,530 | 4,965,769 | Jun 04, 2021, 04:31 PM |
| Grunberg Gregory | Director | Apr 21, 2021 | Sale | $27.60 | 850 | 23,460 | 0 | Apr 23, 2021, 05:27 PM |
| Waisbourd Ram | See Remarks | Mar 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Mar 17, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Mar 16, 2021 | Sale | $24.20 | 7,000 | 169,400 | 0 | Mar 17, 2021, 04:30 PM |
| Hayden Michael R | Director | Feb 23, 2021 | Option Exercise | $2.13 | 80,904 | 172,236 | 80,904 | Feb 25, 2021, 05:01 PM |
| Waisbourd Ram | See Remarks | Feb 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Feb 17, 2021, 04:22 PM |
| Waisbourd Ram | See Remarks | Feb 16, 2021 | Sale | $23.39 | 7,000 | 163,730 | 0 | Feb 17, 2021, 04:22 PM |
| Waisbourd Ram | See Remarks | Jan 19, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Jan 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Jan 19, 2021 | Sale | $21.16 | 7,000 | 148,120 | 0 | Jan 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Dec 16, 2020 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Dec 18, 2020, 05:00 PM |
| Waisbourd Ram | See Remarks | Dec 16, 2020 | Sale | $27.04 | 7,000 | 189,280 | 0 | Dec 18, 2020, 05:00 PM |
| Le-Nguyen Quoc | See Remarks | Nov 16, 2020 | Option Exercise | $3.11 | 4,548 | 14,144 | 4,548 | Nov 18, 2020, 04:00 PM |
| Le-Nguyen Quoc | See Remarks | Nov 16, 2020 | Sale | $28.11 | 4,548 | 127,844 | 0 | Nov 18, 2020, 04:00 PM |
| Waisbourd Ram | COO and Chief Business Officer | Nov 16, 2020 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Nov 18, 2020, 04:00 PM |
| Waisbourd Ram | COO and Chief Business Officer | Nov 16, 2020 | Sale | $27.39 | 7,000 | 191,730 | 0 | Nov 18, 2020, 04:00 PM |
| ORBIMED ADVISORS LLC | Director | Sep 21, 2020 | Sale | $28.00 | 275,000 | 7,700,000 | 1,864,721 | Sep 23, 2020, 05:09 PM |
| Naschitz Anat | Director | Sep 21, 2020 | Sale | $28.00 | 275,000 | 7,700,000 | 1,864,721 | Sep 23, 2020, 05:04 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Sep 17, 2020 | Buy | $28.00 | 1,300,000 | 36,400,000 | 4,736,214 | Sep 21, 2020, 04:30 PM |
| Longitude Capital Partners III, LLC | 10% Owner | Jul 10, 2020 | Buy | $27.50 | 109,090 | 2,999,975 | 2,600,877 | Jul 14, 2020, 08:11 PM |
| Grunberg Gregory | Director | Jul 10, 2020 | Buy | $27.50 | 109,090 | 2,999,975 | 2,600,877 | Jul 14, 2020, 08:08 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jul 08, 2020 | Buy | $27.50 | 275,000 | 7,562,500 | 3,436,214 | Jul 10, 2020, 04:32 PM |
| Kariv Tomer | Director | Nov 11, 2019 | Buy | $16.00 | 250,000 | 4,000,000 | 250,000 | Nov 13, 2019, 07:10 PM |
| Naschitz Anat | Director | Nov 11, 2019 | Buy | $16.00 | 837,500 | 13,400,000 | 724,363 | Nov 13, 2019, 07:07 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Nov 11, 2019 | Buy | $16.00 | 1,500,000 | 24,000,000 | 1,500,000 | Nov 13, 2019, 07:06 PM |
| Grunberg Gregory | Director | Nov 11, 2019 | Buy | $16.00 | 575,000 | 9,200,000 | 575,000 | Nov 13, 2019, 07:04 PM |
| Hayden Michael R | Director | Nov 11, 2019 | Buy | $16.00 | 18,750 | 300,000 | 18,750 | Nov 13, 2019, 07:02 PM |
| Longitude Capital Partners III, LLC | 10% Owner | Nov 11, 2019 | Buy | $16.00 | 575,000 | 9,200,000 | 575,000 | Nov 13, 2019, 07:02 PM |
| ORBIMED ADVISORS LLC | Director | Nov 11, 2019 | Buy | $16.00 | 837,500 | 13,400,000 | 724,363 | Nov 13, 2019, 07:00 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| RA CAPITAL MANAGEMENT, L.P. | Director | 04/11/2024 | 7,499,996 |
| PALEKAR ROHAN | Chief Executive Officer | 04/01/2024 | 48,250 |
| PALEKAR ROHAN | Chief Executive Officer | 04/01/2024 | 575,153 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 03/04/2024 | 20,722,501 |
| PALEKAR ROHAN | Chief Executive Officer | 02/26/2024 | 48,173 |
| Martins Ryan | Chief Financial Officer | 02/17/2024 | 7,578 |
| PALEKAR ROHAN | Chief Executive Officer | 02/17/2024 | 44,823 |
| Le-Nguyen Quoc | See Remarks | 02/17/2024 | 10,188 |
| Mansbach Harry H | Chief Medical Officer | 02/17/2024 | 10,188 |
| Martins Ryan | Chief Financial Officer | 02/09/2024 | 30,150 |
| Mansbach Harry H | Chief Medical Officer | 02/09/2024 | 30,150 |
| Le-Nguyen Quoc | See Remarks | 02/09/2024 | 30,150 |
| PALEKAR ROHAN | Chief Executive Officer | 02/09/2024 | 107,061 |
| Mansbach Harry H | Chief Medical Officer | 02/05/2024 | 11,662 |
| Le-Nguyen Quoc | See Remarks | 02/05/2024 | 11,662 |
| PALEKAR ROHAN | Chief Executive Officer | 02/05/2024 | 49,666 |
| Martins Ryan | Chief Financial Officer | 02/05/2024 | 8,742 |
| Mansbach Harry H | Chief Medical Officer | 01/05/2024 | 111,507 |
| Martins Ryan | Chief Financial Officer | 01/05/2024 | 70,610 |
| Le-Nguyen Quoc | See Remarks | 01/05/2024 | 111,507 |
| PALEKAR ROHAN | Chief Executive Officer | 01/05/2024 | 317,202 |
| PALEKAR ROHAN | Chief Executive Officer | 12/29/2023 | 96,500 |
| PALEKAR ROHAN | Chief Executive Officer | 12/29/2023 | 560,000 |
| Mansbach Harry H | Chief Medical Officer | 09/09/2023 | 63,467 |
| Martins Ryan | Chief Financial Officer | 09/09/2023 | 34,449 |
| Le-Nguyen Quoc | See Remarks | 09/09/2023 | 82,352 |
| Mansbach Harry H | Chief Medical Officer | 08/17/2023 | 15,676 |
| Mansbach Harry H | Chief Medical Officer | 08/01/2023 | 9,024 |
| PALEKAR ROHAN | Chief Executive Officer | 08/17/2023 | 69,585 |
| Martins Ryan | Chief Financial Officer | 08/01/2023 | 5,411 |
| Martins Ryan | Chief Financial Officer | 08/17/2023 | 11,641 |
| Le-Nguyen Quoc | See Remarks | 08/01/2023 | 24,701 |
| LAPORTE KATHLEEN | Director | 07/17/2023 | 33,000 |
| LAPORTE KATHLEEN | Director | 07/17/2023 | 235,000 |
| Mansbach Harry H | Chief Medical Officer | 06/30/2023 | 54,614 |
| Le-Nguyen Quoc | See Remarks | 06/30/2023 | 54,614 |
| PALEKAR ROHAN | Chief Executive Officer | 06/30/2023 | 313,187 |
| Martins Ryan | Chief Financial Officer | 06/30/2023 | 38,241 |
| PALEKAR ROHAN | Chief Executive Officer | 06/05/2023 | 28,950 |
| PALEKAR ROHAN | Chief Executive Officer | 06/05/2023 | 300,000 |
| Atkinson Edward Morrow III | Director | 06/01/2023 | 16,312 |
| Atkinson Edward Morrow III | Director | 06/01/2023 | 111,937 |
| Le-Nguyen Quoc | See Remarks | 05/09/2023 | 247,466 |
| Le-Nguyen Quoc | See Remarks | 05/09/2023 | 247,799 |
| Martins Ryan | Chief Financial Officer | 04/04/2023 | 130,379 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 03/24/2023 | 39,999,993 |
| Hayden Michael R | Director | 03/30/2022 | 22,625 |
| Hayden Michael R | Director | 03/28/2023 | 993,839 |
| Hayden Michael R | Director | 04/25/2022 | 26,700 |
| Hayden Michael R | Director | 04/07/2022 | 34,750 |
| Martins Ryan | Chief Financial Officer | 03/23/2023 | 80,550 |
| PALEKAR ROHAN | Chief Executive Officer | 03/23/2023 | 240,000 |
| Mansbach Harry H | Chief Medical Officer | 02/17/2023 | 29,714 |
| Martins Ryan | Chief Financial Officer | 02/17/2023 | 24,448 |
| Martins Ryan | Chief Financial Officer | 02/21/2023 | 35,281 |
| Le-Nguyen Quoc | See Remarks | 02/17/2023 | 29,896 |
| PALEKAR ROHAN | Chief Executive Officer | 02/17/2023 | 87,718 |
| Martins Ryan | Chief Financial Officer | 02/08/2023 | 21,327 |
| Mansbach Harry H | Chief Medical Officer | 02/05/2023 | 18,006 |
| PALEKAR ROHAN | Chief Executive Officer | 02/05/2023 | 53,993 |
| Martins Ryan | Chief Financial Officer | 02/05/2023 | 7,838 |
| Martins Ryan | Chief Financial Officer | 02/03/2023 | 9,330 |
| Martins Ryan | Chief Financial Officer | 02/03/2023 | 46,848 |
| Le-Nguyen Quoc | See Remarks | 02/05/2023 | 18,404 |
| Martins Ryan | Chief Financial Officer | 02/01/2023 | 4,916 |
| Mansbach Harry H | Chief Medical Officer | 02/01/2023 | 8,194 |
| Le-Nguyen Quoc | See Remarks | 02/01/2023 | 8,375 |
| Martins Ryan | Chief Financial Officer | 01/03/2023 | 74,397 |
| Mansbach Harry H | Chief Medical Officer | 11/15/2022 | 30,476 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 10/18/2022 | 8,971,469 |
| Le-Nguyen Quoc | See Remarks | 09/30/2022 | 7,510 |
| Le-Nguyen Quoc | See Remarks | 09/28/2022 | 16,600 |
| Martins Ryan | Chief Financial Officer | 09/28/2022 | 11,624 |
| Mansbach Harry H | Chief Medical Officer | 09/28/2022 | 16,600 |
| PALEKAR ROHAN | Chief Executive Officer | 09/28/2022 | 66,396 |
| PALEKAR ROHAN | Chief Executive Officer | 09/08/2022 | 193,000 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 07/01/2022 | 9,999,995 |
| Mansbach Harry H | Chief Medical Officer | 02/05/2022 | 7,128 |
| Martins Ryan | Chief Financial Officer | 02/05/2022 | 5,345 |
| PALEKAR ROHAN | Chief Executive Officer | 02/05/2022 | 21,380 |
| Le-Nguyen Quoc | See Remarks | 02/05/2022 | 7,128 |
| Waisbourd Ram | See Remarks | 02/01/2022 | 13,510 |
| Waisbourd Ram | See Remarks | 02/01/2022 | 39,900 |
| PALEKAR ROHAN | Chief Executive Officer | 01/28/2022 | 15,350 |
| PALEKAR ROHAN | Chief Executive Officer | 01/27/2022 | 37,500 |
| ORBIMED ADVISORS LLC | 10% Owner | 01/26/2022 | 180,019 |
| ORBIMED ADVISORS LLC | 10% Owner | 01/25/2022 | 412,364 |
| Waisbourd Ram | See Remarks | 12/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 12/16/2021 | 80,360 |
| Waisbourd Ram | See Remarks | 11/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 11/16/2021 | 115,430 |
| Waisbourd Ram | See Remarks | 10/18/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 10/18/2021 | 122,430 |
| Waisbourd Ram | See Remarks | 09/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 09/16/2021 | 136,220 |
| Waisbourd Ram | See Remarks | 08/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 08/16/2021 | 127,960 |
| Waisbourd Ram | See Remarks | 07/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 07/16/2021 | 117,600 |
| PALEKAR ROHAN | Chief Executive Officer | 07/08/2021 | 32,500 |
| PALEKAR ROHAN | Chief Executive Officer | 07/07/2021 | 85,350 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 06/02/2021 | 415,530 |
| Grunberg Gregory | Director | 04/21/2021 | 23,460 |
| Waisbourd Ram | See Remarks | 03/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 03/16/2021 | 169,400 |
| Hayden Michael R | Director | 02/23/2021 | 172,236 |
| Waisbourd Ram | See Remarks | 02/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 02/16/2021 | 163,730 |
| Waisbourd Ram | See Remarks | 01/19/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 01/19/2021 | 148,120 |
| Waisbourd Ram | See Remarks | 12/16/2020 | 13,510 |
| Waisbourd Ram | See Remarks | 12/16/2020 | 189,280 |
| Le-Nguyen Quoc | See Remarks | 11/16/2020 | 14,144 |
| Le-Nguyen Quoc | See Remarks | 11/16/2020 | 127,844 |
| Waisbourd Ram | COO and Chief Business Officer | 11/16/2020 | 13,510 |
| Waisbourd Ram | COO and Chief Business Officer | 11/16/2020 | 191,730 |
| ORBIMED ADVISORS LLC | Director | 09/21/2020 | 7,700,000 |
| Naschitz Anat | Director | 09/21/2020 | 7,700,000 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 09/17/2020 | 36,400,000 |
| Longitude Capital Partners III, LLC | 10% Owner | 07/10/2020 | 2,999,975 |
| Grunberg Gregory | Director | 07/10/2020 | 2,999,975 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 07/08/2020 | 7,562,500 |
| Kariv Tomer | Director | 11/11/2019 | 4,000,000 |
| Naschitz Anat | Director | 11/11/2019 | 13,400,000 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 11/11/2019 | 24,000,000 |
| Grunberg Gregory | Director | 11/11/2019 | 9,200,000 |
| Hayden Michael R | Director | 11/11/2019 | 300,000 |
| Longitude Capital Partners III, LLC | 10% Owner | 11/11/2019 | 9,200,000 |
| ORBIMED ADVISORS LLC | Director | 11/11/2019 | 13,400,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN 89BIO INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 12,766,948 | 3.06% | 11.82% | Other |
| BLACKROCK INC. | 5,454,196 | 0.00155% | 9.83% | Other |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,888,434 | 2.47% | 81.43% | Growth At A Reasonable Price |
| HOLOCENE ADVISORS, LP | 3,490,628 | 0.15% | 56.12% | Growth At A Reasonable Price |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,125,000 | 0.07% | 83.99% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,377,710 | 0.00161% | 6.47% | Other |
| CANDRIAM S.C.A. | 280,000 | 0.02% | 27.27% | Other |
| UBS OCONNOR LLC | 79,075 | 0.06% | -20% | Value |
| ALPS ADVISORS INC | 52,456 | 0.00461% | -5.77% | Other |
| D. E. SHAW & CO., INC. | 13,957 | 0.00014% | -23.75% | Other |
CHANGE IN SHARES OUTSTANDING FOR 89BIO INC
STOCK BUYBACKS FOR 89BIO INC
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
5.85%
1Q
06/30/2023
9.01%
2Q
09/30/2022
71.00%
5Q
BUYBACK ANNOUNCEMENT(S) FOR 89BIO INC
LOADING...